nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—GSTP1—blood plasma—abdominal aortic aneurysm	0.0311	0.0973	CbGeAlD
Clomipramine—HTR2A—hindlimb—abdominal aortic aneurysm	0.0298	0.0932	CbGeAlD
Clomipramine—SLC6A4—blood plasma—abdominal aortic aneurysm	0.0259	0.081	CbGeAlD
Clomipramine—CYP2C19—blood plasma—abdominal aortic aneurysm	0.0214	0.0671	CbGeAlD
Clomipramine—HTR2A—artery—abdominal aortic aneurysm	0.0183	0.0571	CbGeAlD
Clomipramine—CYP1A2—blood plasma—abdominal aortic aneurysm	0.0175	0.0548	CbGeAlD
Clomipramine—GSTP1—connective tissue—abdominal aortic aneurysm	0.0166	0.0518	CbGeAlD
Clomipramine—ADRA2A—blood plasma—abdominal aortic aneurysm	0.0161	0.0504	CbGeAlD
Clomipramine—GSTP1—kidney—abdominal aortic aneurysm	0.0141	0.0441	CbGeAlD
Clomipramine—HTR2A—blood plasma—abdominal aortic aneurysm	0.0137	0.0429	CbGeAlD
Clomipramine—CYP3A4—blood plasma—abdominal aortic aneurysm	0.0127	0.0397	CbGeAlD
Clomipramine—CYP2D6—blood plasma—abdominal aortic aneurysm	0.0125	0.039	CbGeAlD
Clomipramine—GSTP1—spinal cord—abdominal aortic aneurysm	0.011	0.0344	CbGeAlD
Clomipramine—HTR2C—spinal cord—abdominal aortic aneurysm	0.00964	0.0302	CbGeAlD
Clomipramine—SLC6A4—spinal cord—abdominal aortic aneurysm	0.00914	0.0286	CbGeAlD
Clomipramine—ABCB1—blood plasma—abdominal aortic aneurysm	0.00898	0.0281	CbGeAlD
Clomipramine—ADRA2A—connective tissue—abdominal aortic aneurysm	0.00858	0.0268	CbGeAlD
Clomipramine—HTR2A—connective tissue—abdominal aortic aneurysm	0.00729	0.0228	CbGeAlD
Clomipramine—HTR2A—kidney—abdominal aortic aneurysm	0.00621	0.0194	CbGeAlD
Clomipramine—CYP3A4—kidney—abdominal aortic aneurysm	0.00575	0.018	CbGeAlD
Clomipramine—ADRA2A—spinal cord—abdominal aortic aneurysm	0.00569	0.0178	CbGeAlD
Clomipramine—CYP2D6—kidney—abdominal aortic aneurysm	0.00566	0.0177	CbGeAlD
Clomipramine—HTR2A—spinal cord—abdominal aortic aneurysm	0.00483	0.0151	CbGeAlD
Clomipramine—ABCB1—kidney—abdominal aortic aneurysm	0.00407	0.0127	CbGeAlD
Clomipramine—ABCB1—spinal cord—abdominal aortic aneurysm	0.00317	0.00991	CbGeAlD
Clomipramine—CYP1A2—Melatonin metabolism and effects—NFKB1—abdominal aortic aneurysm	0.0029	0.00426	CbGpPWpGaD
Clomipramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—abdominal aortic aneurysm	0.00284	0.00418	CbGpPWpGaD
Clomipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—abdominal aortic aneurysm	0.00283	0.00416	CbGpPWpGaD
Clomipramine—ALB—Folate Metabolism—SERPINE1—abdominal aortic aneurysm	0.00283	0.00416	CbGpPWpGaD
Clomipramine—HTR2C—GPCRs, Class A Rhodopsin-like—AGTR1—abdominal aortic aneurysm	0.00282	0.00414	CbGpPWpGaD
Clomipramine—CYP2C19—Arachidonic acid metabolism—PTGS2—abdominal aortic aneurysm	0.00277	0.00407	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00275	0.00404	CbGpPWpGaD
Clomipramine—SLC6A2—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.00269	0.00396	CbGpPWpGaD
Clomipramine—GSTP1—Cellular responses to stress—NFKB1—abdominal aortic aneurysm	0.00269	0.00396	CbGpPWpGaD
Clomipramine—SLC6A4—Circadian rythm related genes—SERPINE1—abdominal aortic aneurysm	0.00269	0.00395	CbGpPWpGaD
Clomipramine—ALB—SLC-mediated transmembrane transport—AAAS—abdominal aortic aneurysm	0.00266	0.00391	CbGpPWpGaD
Clomipramine—ALB—Vitamin B12 Metabolism—NFKB1—abdominal aortic aneurysm	0.00264	0.00387	CbGpPWpGaD
Clomipramine—HTR2A—GPCR ligand binding—P2RY12—abdominal aortic aneurysm	0.00262	0.00386	CbGpPWpGaD
Clomipramine—HTR2C—G alpha (q) signalling events—AGT—abdominal aortic aneurysm	0.00257	0.00377	CbGpPWpGaD
Clomipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—abdominal aortic aneurysm	0.00252	0.00371	CbGpPWpGaD
Clomipramine—HTR6—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.0025	0.00367	CbGpPWpGaD
Clomipramine—SLC6A4—SIDS Susceptibility Pathways—NFKB1—abdominal aortic aneurysm	0.00249	0.00366	CbGpPWpGaD
Clomipramine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—abdominal aortic aneurysm	0.00248	0.00364	CbGpPWpGaD
Clomipramine—HRH2—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.00248	0.00364	CbGpPWpGaD
Clomipramine—HTR2A—GPCRs, Class A Rhodopsin-like—AGTR1—abdominal aortic aneurysm	0.00245	0.0036	CbGpPWpGaD
Clomipramine—ALB—Platelet degranulation—SERPINE1—abdominal aortic aneurysm	0.00243	0.00357	CbGpPWpGaD
Clomipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGTR1—abdominal aortic aneurysm	0.00242	0.00355	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—AAAS—abdominal aortic aneurysm	0.00241	0.00355	CbGpPWpGaD
Clomipramine—ALB—Selenium Micronutrient Network—CCL2—abdominal aortic aneurysm	0.00241	0.00354	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—P2RY12—abdominal aortic aneurysm	0.00239	0.00351	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—SELL—abdominal aortic aneurysm	0.00237	0.00348	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00232	0.00341	CbGpPWpGaD
Clomipramine—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—abdominal aortic aneurysm	0.00231	0.0034	CbGpPWpGaD
Clomipramine—HTR6—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.00231	0.00339	CbGpPWpGaD
Clomipramine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—abdominal aortic aneurysm	0.00231	0.00339	CbGpPWpGaD
Clomipramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—abdominal aortic aneurysm	0.0023	0.00337	CbGpPWpGaD
Clomipramine—HRH2—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.00229	0.00337	CbGpPWpGaD
Clomipramine—HTR2B—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.00228	0.00335	CbGpPWpGaD
Clomipramine—ALB—Selenium Micronutrient Network—SERPINE1—abdominal aortic aneurysm	0.00225	0.0033	CbGpPWpGaD
Clomipramine—HTR2A—G alpha (q) signalling events—AGT—abdominal aortic aneurysm	0.00223	0.00327	CbGpPWpGaD
Clomipramine—ADRA2A—GPCRs, Class A Rhodopsin-like—AGTR1—abdominal aortic aneurysm	0.00223	0.00327	CbGpPWpGaD
Clomipramine—CYP1A2—Arachidonic acid metabolism—PTGS2—abdominal aortic aneurysm	0.00216	0.00317	CbGpPWpGaD
Clomipramine—ALB—Folate Metabolism—NFKB1—abdominal aortic aneurysm	0.00214	0.00315	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—P2RY12—abdominal aortic aneurysm	0.00213	0.00314	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00212	0.00311	CbGpPWpGaD
Clomipramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.00211	0.0031	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00211	0.0031	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—LDLR—abdominal aortic aneurysm	0.00211	0.00309	CbGpPWpGaD
Clomipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—abdominal aortic aneurysm	0.0021	0.00308	CbGpPWpGaD
Clomipramine—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—abdominal aortic aneurysm	0.002	0.00294	CbGpPWpGaD
Clomipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—abdominal aortic aneurysm	0.00199	0.00293	CbGpPWpGaD
Clomipramine—ALB—Selenium Micronutrient Network—PTGS2—abdominal aortic aneurysm	0.00196	0.00289	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00192	0.00283	CbGpPWpGaD
Clomipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—abdominal aortic aneurysm	0.00191	0.0028	CbGpPWpGaD
Clomipramine—HTR6—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.0019	0.00279	CbGpPWpGaD
Clomipramine—HRH2—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.00189	0.00277	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—SELL—abdominal aortic aneurysm	0.00187	0.00275	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00184	0.0027	CbGpPWpGaD
Clomipramine—HTR2C—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.00184	0.0027	CbGpPWpGaD
Clomipramine—HTR6—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.00176	0.00258	CbGpPWpGaD
Clomipramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.00173	0.00255	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00173	0.00255	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00171	0.00251	CbGpPWpGaD
Clomipramine—ALB—Selenium Micronutrient Network—NFKB1—abdominal aortic aneurysm	0.0017	0.0025	CbGpPWpGaD
Clomipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.0017	0.0025	CbGpPWpGaD
Clomipramine—ADRA2A—G alpha (i) signalling events—AGT—abdominal aortic aneurysm	0.00169	0.00248	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—P2RY12—abdominal aortic aneurysm	0.00168	0.00248	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.00167	0.00246	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00162	0.00238	CbGpPWpGaD
Clomipramine—HTR2B—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.0016	0.00236	CbGpPWpGaD
Clomipramine—HTR2A—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.0016	0.00235	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00155	0.00228	CbGpPWpGaD
Clomipramine—HTR2A—SIDS Susceptibility Pathways—NFKB1—abdominal aortic aneurysm	0.0015	0.00221	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00149	0.00219	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00148	0.00218	CbGpPWpGaD
Clomipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.00148	0.00217	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.00145	0.00214	CbGpPWpGaD
Clomipramine—HTR6—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.00145	0.00213	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00141	0.00207	CbGpPWpGaD
Clomipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.0014	0.00206	CbGpPWpGaD
Clomipramine—ADRA2A—Platelet activation, signaling and aggregation—SERPINE1—abdominal aortic aneurysm	0.00136	0.002	CbGpPWpGaD
Clomipramine—ALB—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.00135	0.00199	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00135	0.00198	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00135	0.00198	CbGpPWpGaD
Clomipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.00134	0.00197	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00133	0.00195	CbGpPWpGaD
Clomipramine—HTR2B—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.00132	0.00194	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00131	0.00193	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.00129	0.0019	CbGpPWpGaD
Clomipramine—HTR2C—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.00129	0.0019	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00129	0.00189	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.00128	0.00188	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00124	0.00183	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.00124	0.00183	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00123	0.00181	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00123	0.0018	CbGpPWpGaD
Clomipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.00122	0.00179	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00121	0.00178	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.00119	0.00174	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.00118	0.00173	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.00117	0.00172	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00114	0.00168	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00114	0.00167	CbGpPWpGaD
Clomipramine—HTR2A—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.00112	0.00165	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.00112	0.00164	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—AGT—abdominal aortic aneurysm	0.00111	0.00164	CbGpPWpGaD
Clomipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.00111	0.00163	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—APOE—abdominal aortic aneurysm	0.00109	0.0016	CbGpPWpGaD
Clomipramine—ALB—Platelet activation, signaling and aggregation—SERPINE1—abdominal aortic aneurysm	0.00108	0.00158	CbGpPWpGaD
Clomipramine—HTR2C—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.00107	0.00157	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00104	0.00153	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00104	0.00153	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.00102	0.0015	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00101	0.00148	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000993	0.00146	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000987	0.00145	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000979	0.00144	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000968	0.00142	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000944	0.00139	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000943	0.00139	CbGpPWpGaD
Clomipramine—HTR2A—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.000926	0.00136	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—abdominal aortic aneurysm	0.000925	0.00136	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00092	0.00135	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000916	0.00135	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000907	0.00133	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.000903	0.00133	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000902	0.00133	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.00088	0.00129	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.000869	0.00128	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000861	0.00126	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000851	0.00125	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.000842	0.00124	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000841	0.00124	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—NOS2—abdominal aortic aneurysm	0.000835	0.00123	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000823	0.00121	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.000821	0.00121	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.00082	0.0012	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—AAAS—abdominal aortic aneurysm	0.000803	0.00118	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.000803	0.00118	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000796	0.00117	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000774	0.00114	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000757	0.00111	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—PTGS2—abdominal aortic aneurysm	0.000747	0.0011	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000746	0.0011	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000743	0.00109	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000742	0.00109	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000731	0.00107	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00073	0.00107	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000724	0.00106	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.000703	0.00103	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—LDLR—abdominal aortic aneurysm	0.000701	0.00103	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000695	0.00102	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000694	0.00102	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000691	0.00102	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000681	0.001	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000678	0.000996	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000675	0.000992	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000665	0.000977	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000664	0.000976	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—NOS2—abdominal aortic aneurysm	0.000659	0.000968	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000657	0.000965	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000645	0.000947	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.000644	0.000946	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000635	0.000933	CbGpPWpGaD
Clomipramine—ALB—Metabolism—AAAS—abdominal aortic aneurysm	0.000634	0.000932	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000616	0.000905	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000603	0.000886	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.00059	0.000867	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000586	0.000862	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000578	0.000849	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.000578	0.000849	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000577	0.000848	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000572	0.000841	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—AAAS—abdominal aortic aneurysm	0.000569	0.000836	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000558	0.000819	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—AAAS—abdominal aortic aneurysm	0.000556	0.000816	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.000555	0.000815	CbGpPWpGaD
Clomipramine—ALB—Metabolism—LDLR—abdominal aortic aneurysm	0.000554	0.000813	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000549	0.000806	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000547	0.000804	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000534	0.000785	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000533	0.000783	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000525	0.000771	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—AAAS—abdominal aortic aneurysm	0.000523	0.000769	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000522	0.000767	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000497	0.00073	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—LDLR—abdominal aortic aneurysm	0.000497	0.00073	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000486	0.000715	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—LDLR—abdominal aortic aneurysm	0.000485	0.000713	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000484	0.000712	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000476	0.0007	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000475	0.000698	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000459	0.000675	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—LDLR—abdominal aortic aneurysm	0.000457	0.000672	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.00045	0.000662	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—AAAS—abdominal aortic aneurysm	0.000443	0.000652	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.000441	0.000648	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.00044	0.000647	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000439	0.000645	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000432	0.000635	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000432	0.000634	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.00041	0.000602	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000409	0.000601	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000405	0.000595	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.0004	0.000589	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.000396	0.000582	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000393	0.000577	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000392	0.000577	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—LDLR—abdominal aortic aneurysm	0.000387	0.000569	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000384	0.000565	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000374	0.000549	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—AGT—abdominal aortic aneurysm	0.000371	0.000545	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—APOE—abdominal aortic aneurysm	0.000363	0.000534	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—AAAS—abdominal aortic aneurysm	0.000342	0.000503	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000341	0.000501	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000334	0.000491	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000323	0.000475	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000314	0.000461	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.00031	0.000456	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—AGT—abdominal aortic aneurysm	0.00031	0.000456	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.000308	0.000453	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000304	0.000446	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000302	0.000443	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—LDLR—abdominal aortic aneurysm	0.000299	0.000439	CbGpPWpGaD
Clomipramine—ALB—Metabolism—AGT—abdominal aortic aneurysm	0.000293	0.00043	CbGpPWpGaD
Clomipramine—ALB—Metabolism—APOE—abdominal aortic aneurysm	0.000287	0.000421	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000286	0.000421	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000283	0.000416	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000281	0.000412	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—AGT—abdominal aortic aneurysm	0.000263	0.000386	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000262	0.000385	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—APOE—abdominal aortic aneurysm	0.000257	0.000378	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—AGT—abdominal aortic aneurysm	0.000256	0.000377	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000255	0.000375	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—APOE—abdominal aortic aneurysm	0.000251	0.000369	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PTGS2—abdominal aortic aneurysm	0.000249	0.000366	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—AGT—abdominal aortic aneurysm	0.000242	0.000355	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000238	0.00035	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—APOE—abdominal aortic aneurysm	0.000237	0.000348	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000231	0.00034	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000229	0.000336	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—AGT—abdominal aortic aneurysm	0.000205	0.000301	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000201	0.000295	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—APOE—abdominal aortic aneurysm	0.0002	0.000295	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000199	0.000292	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PTGS2—abdominal aortic aneurysm	0.000196	0.000289	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000183	0.000268	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000181	0.000265	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PTGS2—abdominal aortic aneurysm	0.000176	0.000259	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PTGS2—abdominal aortic aneurysm	0.000172	0.000253	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PTGS2—abdominal aortic aneurysm	0.000162	0.000238	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—AGT—abdominal aortic aneurysm	0.000158	0.000232	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—APOE—abdominal aortic aneurysm	0.000155	0.000227	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PTGS2—abdominal aortic aneurysm	0.000137	0.000202	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PTGS2—abdominal aortic aneurysm	0.000106	0.000156	CbGpPWpGaD
